8/13/2019 DAFTAR PUSTAKA Dhika

1/3

DAFTAR PUSTAKA

1. Bagian Obstetri Ginekologi FK UNPAD. Penyakit Trofoblas Gestasional;Obstetri Patologi; 1983; 28-33.

2. Cunningham FG, Gant NF, Leveno KJ, et al. Gestational TrophoblasticDisease : Williams Obstetrics.21th ed. Conneticut, Appleton & Lange, 2002;

835-843.

3. Winkjosastro H. Mola Hidatidosa ;Ilmu Kebidanan. Edisi ke-3. Jakarta.Yayasan Bina Pustaka Sarwono Prawirohardjo; 1999 : Hal: 142, 339- 348.

4. Rustam Muchtar. Penyakit Trofoblas :Sinopsis Obstetri. Edisi 2, Jilid 1.Penerbit buku Kedokteran. EGC. Hal. 238-243.

5. Lurain JR. Gestational trophoblastic disease I: epidemiology,pathology,clinical presentation and diagnosis of gestational trophoblasticdisease, and management of hydatidiform mole. American Journal of

Obstetrics & Gynecology 2010: 531-539.

6. Ilancheran A. Optimal Treatment in Gestational Trophoblastic Disease. AnnAcad Med Singapore 1998; 27:698-704.

7. Syafii, Aprianti S, Hardjoeno . Kadar B-Hcg Penderita Mola HidatidosaSebelum Dan Sesudah Kuretase. Indonesian Journal Of Clinical Pathology

And Medical Laboratory, Vol. 13, No. 1, Nov. 2006: 1-3.

8. Berkowitz RS, Goldstein DP, Marean AR, et al. Oral contraceptives andpostmolar gestational trophoblastic disease. ObstetGynecol 1981;58:474-7.

9. Curry SL, Schlaerth JB, Kohorn EI, et al. Hormonal contraception andtrophoblastic se-quelae after hydatidiform mole (a gynecologic oncology

group study). Am J ObstetGynecol 1989;160:805-11.

10.Deicas RE, Miller DS, Rademaker AW, et al. The role of contraception in thedevelopment of postmolar gestational trophoblastic tumor. Obstet Gynecol

1991;78:221-6.

8/13/2019 DAFTAR PUSTAKA Dhika

2/3

11.Moore LE. Hydatidiform Mole Follow-up. Available athttp://emedicine.medscape.com/article/254657-followup. diakses 17 Juli

2013.

12.Sebire NJ ,Seckl MJ. Clinical review: gestational trophoblastic disease:current management of hydatidiform mole. Bmj 2008; 337: 453-458.

13.Lurain JR. Gestational trophoblastic disease: epidemiology, pathology,clinical presentation and diagnosis of gestational trophoblastic disease, and

management of hydatidiform mole. American Journal of Obstetrics &

Gynecology. 2010.

14.Hunter CL. Molar Pregnancy With False Negative -hCG Urine In TheEmergency Department. West J Emerg Med 2011;12(2):213-15.

15.Cunningham FG, Leveno KJ, Bloom SL et al. Gestational TrophoblasticDisease, in William Obstetrics. 22

nd . New York, Mc Graw Hill ; 2007 ;

Chapter 11.

16.Society of Gynecologic oncologies, Diagnosis and treatment of gestationaltrophoblastic disease. In : ACOG practice buletin, Clinical managementguidelines for obstetrician and gynecologists number 53, June 2004.

17.Berkowitz RS, Goldstein DP. Gestational Trophoblastic Disease. In: Berek,JS eds Berek and Novaks Gynecology. 14thed.Philadelphia, PA: Lippincott,Wiliams, and Wilkins; 2007:1581-1603.

18.Butch AW. Dilution Protocol For Detection Of Hook effect/ ProzonePhenomenon (Letter To The Editor) Clin Chem. 2000; 46:1719-20.

19.Davison CM, Kaplan RM, Wenig LN, Burmeister D. Qualitative beta-hCGurine assays may be misleading in the presence of molar pregnancy: A casereport. J Emerg Med 2004;27:43-7.

20.Er TK, Jong YJ, Tsai EM, Huang CL, Chou HW, Zheng BH,

et al. False-negative pregnancy test in hydatidiform mole. Clin Chem 2006;52:1616-8.

21.Yadav Y K, Fatima U, Dogra S, Kaushik A. Beware of "hook effect" givingfalse negative pregnancy test on point-of-care kits. J Postgrad Med2013;59:153-4.

8/13/2019 DAFTAR PUSTAKA Dhika

3/3

22.Berry E, Hagopian GS, Lurain JR.Vaginal. Metastases in gestationaltrophoblastic neoplasia. J Reprod Med. 2008;53:487-92.

23.H Alan, De Cherney, Nathan L. Gestational Trophoblastic Disease. In :Current Obstetric Gynecologic Diagnose and Treatment. 10th ed. Lange.

Baltimore NY. Mc Graw Hill. 2007; Chapter 53.

24.Baergen RN,Rutgers JL,Young RH,etal. Placental site trophoblastic tumor:astudy of 55 Cases and review of the literature emphasizing factors of

prognostic significance.Gynecol Oncol2006;100:511-20.

25.AllisonKH,LoveJE,GarciaRL.Epithelioid Trophoblastic Tumor: review of arare neoplasm Of the chorionic-type intermediate trophoblast. Arch Pathol

Lab Med2006;130:1875-7.

26.Erhan Y, Ozdemir N, Zekioglu O, Nart D, Ciris M. Breast carcinomas withhoriocarcinomatous features: case reports and review of the literature. Breast

J. 2002;8(4):2448.

27.Shukla R, Pooja B, Radhika S, Nijhawan R, Rajwanshi A. Fine-needleaspiration cytology of extramammary neoplasms metastatic to the breast.

Diagn Cytopathol. 2005;32(4):1937.

28.Dresang, LT. A Molar Pregnancy Detected by Following HumanChorionicGonadotropin Levels after a First Trimester Loss. JABFP 2005.

29.Gaffield ME, Kapp N, Curtis KM. Combined oral contraceptive andintrauterine device use among women with gestational trophoblastic disease,

Contraception,June 2009 (80); 363-371.

30.Parazzini F, et al. Oral contraceptives and risk of gestationaltrophoblasticdisease. Contraception, June 2002 (65); 425-427.